Abstract:Mycobacteria have high rates of error in the translation of glutamine and asparagine codons due to a two-step indirect tRNA aminoacylation pathway involving the essential amidotransferase GatCAB. This specific mycobacterial mistranslation is both necessary and sufficient for tolerance to the antibiotic rifampicin. Furthermore, we identified the natural product kasugamycin as a small molecule that could decrease this type of translational error, and potentiate rifampicin-mediated killing of mycobacteria, but whether other small molecules can decrease this specific type of mistranslation is unknown. We screened a library of synthetic small molecules using a pathway-specific whole-cell screen in a reporter strain of Mycobacterium smegmatis for their ability to decrease specific mycobacterial mistranslation. We synthesized 110 analogs of a parent hit compound and analyzed their bioactivity. To identify the cellular target of the compounds, we biotinylated active and inactive analogs and performed pull-down and mass-spectrometry of bound cellular proteins. We identified benzo[d]isoxazole-4,7-diones as a class of small molecules able to decrease mycobacterial mistranslation. Of the 110 analogs synthesized, we identified 10 with superior potency to the parent compound and analyzed the compounds to infer structure-activity relationships. Pull-down and mass spectrometry of bound cellular proteins identified RpS5 as a potential target of active compounds. Our study identified synthetic small molecules able to decrease mycobacterial mistranslation and confirmed that the small ribosomal subunit can be targeted to decrease mistranslation rates arising from physiologically mischarged tRNAs. Targeting mistranslation may be a potentially attractive means of targeting antibiotic-tolerant bacteria.

Berberine analog of chloramphenicol exhibits a distinct mode of action and unveils ribosome plasticity

Conjugates of Chloramphenicol Amine and Berberine as Antimicrobial Agents

Discovery of Natural Berberine-Derived Nitroimidazoles As Potentially Multi-Targeting Agents Against Drug-Resistant Escherichia Coli

Discovery of 2-Aminothiazolyl Berberine Derivatives As Effectively Antibacterial Agents Toward Clinically Drug-Resistant Gram-negative Acinetobacter Baumanii.

Structural basis for the context-specific action of the classic peptidyl transferase inhibitor chloramphenicol

Chloramphenicol Interferes with 50S Ribosomal Subunit Maturation via Direct and Indirect Mechanisms

Structural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR Pyrazoles

New Chloramphenicol Derivatives with a Modified Dichloroacetyl Tail as Potential Antimicrobial Agents

A paradox of bacterial persistence and antibiotic resistance: chloramphenicol acetyl transferase as a double barrel shot gun

Context-specific inhibition of mitochondrial ribosomes by phenicol and oxazolidinone antibiotics

Structural basis for the context-specific action of classic peptidyl transferase inhibitors

Recent Trends in Synthesis of Chloramphenicol New Derivatives

Design, synthesis and biological evaluation of berberine-benzimidazole hybrids as new type of potentially DNA-targeting antimicrobial agents.

Tetracenomycin X Inhibits Translation by Binding Within the Ribosomal Exit Tunnel

Medicinal chemistry of benzo[d]isoxazole-4,7-dione analogues identifies the ribosomal small subunit as a target for specific mycobacterial translational fidelity

Biosynthetically Guided Structure-Activity Relationship Studies of Merochlorin A, an Antibiotic Marine Natural Product.

Inhibition of polymorphic MexXY‐OprM efflux system in Pseudomonas aeruginosa clinical isolates by Berberine derivatives

Discovery and evolution of berberine analogues as anti-Helicobacter pylori agents with multi-target mechanisms

Molecular Simplification of Natural Products: Synthesis, Antibacterial Activity, and Molecular Docking Studies of Berberine Open Models

New Chloramphenicol Derivatives from the Viewpoint of Anticancer and Antimicrobial Activity